{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,14]],"date-time":"2026-02-14T08:33:08Z","timestamp":1771057988916,"version":"3.50.1"},"reference-count":10,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2016,7,22]],"date-time":"2016-07-22T00:00:00Z","timestamp":1469145600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Rev Endocrinol"],"published-print":{"date-parts":[[2016,9]]},"DOI":"10.1038\/nrendo.2016.118","type":"journal-article","created":{"date-parts":[[2016,7,22]],"date-time":"2016-07-22T14:00:05Z","timestamp":1469196005000},"page":"502-503","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Mortality in Cushing disease"],"prefix":"10.1038","volume":"12","author":[{"given":"John","family":"Newell-Price","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,7,22]]},"reference":[{"key":"BFnrendo2016118_CR1","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1016\/S0140-6736(14)61375-1","volume":"386","author":"A Lacroix","year":"2015","unstructured":"Lacroix, A., Feelders, R. A., Stratakis, C. A. & Nieman, L. K. Cushing's syndrome. Lancet 386, 913\u2013927 (2015).","journal-title":"Lancet"},{"key":"BFnrendo2016118_CR2","doi-asserted-by":"publisher","first-page":"1605","DOI":"10.1016\/S0140-6736(06)68699-6","volume":"367","author":"J Newell-Price","year":"2006","unstructured":"Newell-Price, J., Bertagna, X., Grossman, A. B. & Nieman, L. K. Cushing's syndrome. Lancet 367, 1605\u20131617 (2006).","journal-title":"Lancet"},{"key":"BFnrendo2016118_CR3","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1016\/S2213-8587(16)00086-3","volume":"4","author":"R Pivonello","year":"2016","unstructured":"Pivonello, R.  et al. Complications of Cushing's syndrome: state of the art. Lancet Diabetes Endocrinol. 4, 611\u2013629 (2016).","journal-title":"Lancet Diabetes Endocrinol."},{"key":"BFnrendo2016118_CR4","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1016\/S2213-8587(16)30005-5","volume":"4","author":"RN Clayton","year":"2016","unstructured":"Clayton, R. N.  et al. Mortality in patients with Cushing's disease more than 10 years after remission: a multicentre, multinational, retrospective cohort study. Lancet Diabetes Endocrinol. 4, 569\u2013576 (2016).","journal-title":"Lancet Diabetes Endocrinol."},{"key":"BFnrendo2016118_CR5","doi-asserted-by":"publisher","first-page":"2807","DOI":"10.1210\/jc.2015-1818","volume":"100","author":"LK Nieman","year":"2015","unstructured":"Nieman, L. K.  et al. Treatment of Cushing's syndrome: an Endocrine Society clinical practice guideline. J. Clin. Endocrinol. Metab. 100, 2807\u20132831 (2015).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BFnrendo2016118_CR6","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1016\/0002-9343(52)90027-2","volume":"13","author":"CM Plotz","year":"1952","unstructured":"Plotz, C. M., Knowlton, A. I. & Ragan, C. The natural history of Cushing's syndrome. Am. J. Med. 13, 597\u2013614 (1952).","journal-title":"Am. J. Med."},{"key":"BFnrendo2016118_CR7","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/S0140-6736(82)92749-0","volume":"2","author":"EJ Ross","year":"1982","unstructured":"Ross, E. J. & Linch, D. C. Cushing's syndrome \u2014 killing disease: discriminatory value of signs and symptoms aiding early diagnosis. Lancet 2, 646\u2013649 (1982).","journal-title":"Lancet"},{"key":"BFnrendo2016118_CR8","doi-asserted-by":"publisher","first-page":"R143","DOI":"10.1530\/EJE-14-0556","volume":"172","author":"FM van Haalen","year":"2015","unstructured":"van Haalen, F. M., Broersen, L. H., Jorgensen, J. O., Pereira, A. M. & Dekkers, O. M. Management of endocrine disease: mortality remains increased in Cushing's disease despite biochemical remission: a systematic review and meta-analysis. Eur. J. Endocrinol. 172, R143\u2013R149 (2015).","journal-title":"Eur. J. Endocrinol."},{"key":"BFnrendo2016118_CR9","doi-asserted-by":"publisher","first-page":"4849","DOI":"10.1210\/jc.2006-0076","volume":"91","author":"R Bergthorsdottir","year":"2006","unstructured":"Bergthorsdottir, R., Leonsson-Zachrisson, M., Oden, A. & Johannsson, G. Premature mortality in patients with Addison's disease: a population-based study. J. Clin. Endocrinol. Metab. 91, 4849\u20134853 (2006).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BFnrendo2016118_CR10","doi-asserted-by":"publisher","first-page":"4216","DOI":"10.1210\/jc.2009-1097","volume":"94","author":"M Sherlock","year":"2009","unstructured":"Sherlock, M.  et al. ACTH deficiency, higher doses of hydrocortisone replacement, and radiotherapy are independent predictors of mortality in patients with acromegaly. J. Clin. Endocrinol. Metab. 94, 4216\u20134223 (2009).","journal-title":"J. Clin. Endocrinol. Metab."}],"container-title":["Nature Reviews Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/nrendo.2016.118.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nrendo.2016.118","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nrendo.2016.118.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,19]],"date-time":"2023-05-19T03:47:47Z","timestamp":1684468067000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/nrendo.2016.118"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,7,22]]},"references-count":10,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2016,9]]}},"alternative-id":["BFnrendo2016118"],"URL":"https:\/\/doi.org\/10.1038\/nrendo.2016.118","relation":{},"ISSN":["1759-5029","1759-5037"],"issn-type":[{"value":"1759-5029","type":"print"},{"value":"1759-5037","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,7,22]]},"assertion":[{"value":"22 July 2016","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The author has received consultancy fees and research support from HRA Pharma, Ipsen and Novartis Pharmaceuticals.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}